decisionhealth Newsletters, Answer Books - 2009 Issue 1 (January)
Coumadin Clinics / QAs to aid use of anticoagulant management codes
Subscribe or sign in to view the full article.
Article Overview
This article addresses common questions about anticoagulant management coding for Coumadin/warfarin patients, with emphasis on how the topic is handled by Medicare and private payers. It discusses CMS commentary, fee schedule resources, bundling concerns, advance beneficiary notices, and the broader context for reporting management services associated with prothrombin time testing and office visit work. The article is aimed at physicians, billing staff, and coding professionals who need a high-level understanding of how these services are discussed in payer policy and coding guidance.
Why This Topic Matters
Anticoagulant management services can affect how routine monitoring, counseling, and related visits are reported and paid. Understanding the payer distinctions and CMS context helps practices avoid billing confusion and identify whether the article is relevant to their workflow.
Article Sections
-
Introduction and frequently asked questions
Introduces the coding topic and frames the article as a set of practical questions about anticoagulant management reporting.
-
Medicare coverage and related office visit reporting
Discusses how Medicare treats the services, including bundled-service concerns and the role of office visit reporting when additional work is documented.
-
Advance beneficiary notice considerations
Addresses whether an ABN is appropriate in the context of Medicare’s coverage position on these services.
-
Private payer pricing and fee schedule resources
Explains how fee schedule resources and relative value information are used when establishing charges for non-Medicare payers.
-
Telephone management of anticoagulated patients
Covers the scenario of managing patients remotely after laboratory testing and the reporting considerations discussed for different payers.
-
Possible future Medicare policy changes
Summarizes discussion of ongoing policy talks and concerns about how future edits or coverage changes could affect reporting.
What You Will Learn
- How the article frames common questions about anticoagulant management reporting
- What payer-related issues are discussed for Medicare versus private payers
- Which general policy topics are raised, including bundling, fee schedules, and ABNs
- How the article treats office-based and telephone-based management scenarios at a high level
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Practice managers
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com